Published October 30, 2025 | Version v1
Dataset Restricted

Clinical Benefit and Predictors of Response to Momelotinib After Ruxolitinib Failure: A Cooperative Real-World Study

Authors/Creators

  • 1. IRCCS Azienda Ospedaliero-Universitaria di Bologna

Contributors

Project leader:

  • 1. ROR icon Istituto di Ematologia di Bologna

Files

Restricted

The record is publicly accessible, but files are restricted. Log in to check if you have access.